Role of the microbiota–gut–heart axis between bile acids and cardiovascular disease
Top Cited Papers
Open Access
- 6 April 2024
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 174, 116567
Abstract
No abstract availableKeywords
Funding Information
- Medical Science and Technology Project of Zhejiang Province
- Shaoxing Bureau of Science and Technology
- Natural Science Foundation of Zhejiang Province (LY18H020008)
- Shantou Science and Technology Project (2018C30029)
This publication has 134 references indexed in Scilit:
- Adolescence and the MicrobiomeThe American Journal of Pathology, 2023
- Beyond stillbirth: association of intrahepatic cholestasis of pregnancy severity and adverse outcomesAmerican Journal of Obstetrics and Gynecology, 2022
- FXR Agonists as Therapy for Liver DiseaseHepatology, 2020
- Activation of the Liver X Receptor Pathway Inhibits HBV Replication in Primary Human HepatocytesHepatology, 2020
- Socioeconomic Status and Cardiovascular Disease: an UpdateCurrent Cardiology Reports, 2017
- Bone Marrow-Derived Mesenchymal Stem Cells Differentiate to Hepatic Myofibroblasts by Transforming Growth Factor-β1 via Sphingosine Kinase/Sphingosine 1-Phosphate (S1P)/S1P Receptor AxisThe American Journal of Pathology, 2012
- A protective antiarrhythmic role of ursodeoxycholic acid in an in vitro rat model of the cholestatic fetal heartHepatology, 2011
- Raised Hepatic Bile Acid Concentrations During Pregnancy in Mice Are Associated with Reduced Farnesoid X Receptor FunctionHepatology, 2010
- Regulation of Multidrug Resistance-Associated Protein 2 by Calcium Signaling in Mouse LiverHepatology, 2010
- Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemiaDiabetologia, 2007